A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Excelsior

Status: Completed

Conditions: Trientine Treatment for Wilson's Disease

Treatments: Drug: Trientine

Study type: Observational

Funder types: Industry

Identifiers

NCT03299829

EB-TR-001

Details and patient eligibility

About

This is a retrospective study to assess the clinical efficacy and safety of trientine in Wilson's disease patients

Full description

In this retrospective study, the investigators will collect and analyze data from reviewing medical history files of larger and long-term follow-up cohorts with Wilson's disease in Taiwan to assess the efficacy and safety of Trientine in Taiwanese Wilson's Disease patients.

Enrollment: 48 patients

Sex: All

Ages: 3 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of Wilson's disease.
• Male or female patients, aged 3 years to 75 years

Exclusion criteria

• Patients with comorbidity which is not related to Wilson's disease.